Skip to main content

Breadcrumb

  1. Home

Submission Tool and Repository Measure Database

As the Centers for Medicare & Medicaid Services (CMS) consensus-based entity (CBE), Battelle Memorial Institute (Battelle) discloses complete information (e.g., full measure specifications, coding logic, algorithms) regarding each measure to the public for the purpose of evaluating, analyzing, or displaying of each measure for endorsement consideration. If an interested party wishes to attain complete measure information for the use and/or implementation of a measure, the interested party should contact the measure steward. Contact information for the measure steward can be found under the “Point of Contact” section of the respective measure page within the Submission Tool and Repository (STAR). Battelle is not responsible for, nor is privy to the measure use agreements that may be established between a measure steward and an interested party.

To obtain a copy of the full measure submission forms for measures endorsed prior to Fall 2022 cycle, please contact [email protected].

No Filters Selected
          CBE ID Sort descending Title Steward Endorsement Cycle Status Date of Last Endorsement Decision
          0220 Adjuvant hormonal therapy is recommended or administered within 1 year (365 days) of diagnosis for women with AJCC T1cN0M0 or Stage IB – Stage III hormone receptor positive breast cancer American College of Surgeons Endorsed
          0221 Needle biopsy to establish diagnosis of cancer precedes surgical excision/resection American College of Surgeons Endorsement Removed
          0222 Patients with early stage breast cancer who have evaluation of the axilla Intermountain Healthcare Endorsement Removed
          0223 Adjuvant chemotherapy is recommended, or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC Stage III (lymph node positive) colon cancer American College of Surgeons Endorsed
          0224 Completeness of pathology reporting American College of Surgeons Endorsement Removed
          0225 At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer American College of Surgeons Endorsement Removed
          0226 Influenza Immunization in the ESRD Population (Facility Level) Kidney Care Quality Alliance Endorsement Removed
          0227 Influenza Immunization Physician Consortium for Performance Improvement Endorsement Removed
          0228 3-Item Care Transition Measure (CTM-3) University of Colorado Center for Bioethics and Humanities Endorsement Removed
          0229 Hospital 30-Day, All-Cause, Risk-Standardized Mortality Rate (RSMR) Following Heart Failure (HF) Hospitalization Centers for Medicare & Medicaid Services Endorsed